KMO and Huntington disease: Regarding a potential pharmacological modulator, UPF 648, a KMO inhibitor, was tested in Htt93Q; 90% of the flies fed with this inhibitor rescued and increased KYNA, and the 3-HK/KYNA ratio subsequently decreased, supporting the idea that the KMO inhibitor drugs reduce the neurodegenerative effects of HD.